ASX:OSP

Osprey Medical Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume1.25 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive OSP News and Ratings via Email

Sign-up to receive the latest news and ratings for Osprey Medical and its competitors with MarketBeat's FREE daily newsletter.


About Osprey Medical

Osprey Medical, Inc., a commercial stage company, provides contrast reduction and monitoring technologies in the United States and internationally. It offers AVERT, AVERT Plus, DyeVert NG, DyeVert Plus System, and DyeVert Plus EZ Systems, which are used to protect patients from the harmful effects of X-ray dye used during commonly performed angiographic imaging procedures. The company was incorporated in 2005 and is headquartered in Minnetonka, Minnesota.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.83 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Osprey Medical (ASX:OSP) Frequently Asked Questions

What stocks does MarketBeat like better than Osprey Medical?

Wall Street analysts have given Osprey Medical a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Osprey Medical wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were Osprey Medical's earnings last quarter?

Osprey Medical, Inc. (ASX:OSP) issued its quarterly earnings results on Wednesday, August, 14th. The company reported ($0.04) earnings per share (EPS) for the quarter.
View Osprey Medical's earnings history
.

Who are Osprey Medical's key executives?

Osprey Medical's management team includes the following people:
  • Mr. Michael McCormick, Pres, CEO & Exec. Director (Age 59, Pay $612.27k)
  • Dr. J. Edward Shapland, Co-Founder
  • Ms. Nancy Ness, VP of Fin. & CFO
  • Mr. Vic Fabano, VP of Operations & IT (Age 59)
  • Ms. Melanie Hess, VP of Regulatory Affairs, Compliance & Quality
  • Mr. Doug Schoenberg, VP of Marketing, Education & Reimbursement (Age 51)
  • Mr. Brendan T. Case C.P.A., BEc, Grad Dip., MComLaw, CPA, Dip FP, Company Sec.

Who are some of Osprey Medical's key competitors?

What other stocks do shareholders of Osprey Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Osprey Medical investors own include Macquarie Group (MQG), Magellan Financial Group (MFG), Medlab Clinical (MDC), FBR (FBR), Evolve Education Group (EVO), Dacian Gold (DCN), Constellation Technologies (CT1), Bingo Industries (BIN), Afterpay (APT) and Alkane Resources (ALK).

What is Osprey Medical's stock symbol?

Osprey Medical trades on the ASX under the ticker symbol "OSP."

How much money does Osprey Medical make?

Osprey Medical has a market capitalization of $0.00 and generates $1.94 million in revenue each year.

What is Osprey Medical's official website?

The official website for Osprey Medical is www.ospreymed.com.

How can I contact Osprey Medical?

The company can be reached via phone at 952-955-8230.


This page was last updated on 9/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.